First Page | Document Content | |
---|---|---|
![]() Date: 2014-10-07 15:06:15Pharmacology Biosimilar Center for Biologics Evaluation and Research Biologic License Application New Drug Application Federal Food Drug and Cosmetic Act Investigational New Drug Food and Drug Administration Medicine Health | Source URL: www.biosimilarslawblog.comDownload Document from Source WebsiteFile Size: 93,78 KBShare Document on Facebook |
![]() | Homologous Use of Human Cells, Tissues, and Cellular and Tissue-Based Products Draft Guidance for Industry and FDA StaffDocID: 1ogsZ - View Document |
![]() | Microsoft Word - GHLF 50 State Network Biosims Brief TPs FINAL.docxDocID: 1gkCa - View Document |
![]() | Global Healthy Living Foundation 515 North Midland Avenue Upper Nyack, New York 10960 USA +1 845 348 0400DocID: 1g1KY - View Document |
![]() | Guidance for Industry Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic Reconstitution for Specified IndicationsDocID: 1fuJJ - View Document |
![]() | DSCSA Implementation: Annual Reporting by Prescription Drug Wholesale Distributors and Third-Party Logistics Providers Guidance for IndustryDocID: 1aZ0Q - View Document |